Literature DB >> 35018573

The haematology of Jamaicans: red cell indices in HbAA, HbAS, HbAC, and HbA-HPFH genotypes.

G R Serjeant1, B E Serjeant2, K P Mason2, F Gibson2, C Osmond3, S L Thein4, M Happich5, A E Kulozik5.   

Abstract

Based in the parish of Manchester in central Jamaica, the Manchester Project offered free detection of haemoglobin genotype to senior classes in 15 secondary schools between 2008 and 2013. Restricting the database to 15,103 students aged 15.0-19.9 years provided an opportunity to examine the red cell characteristics of the different haemoglobin genotypes, including normal (HbAA) in 85.0%, the sickle cell trait (HbAS) in 9.7%, HbC trait (HbAC) in 3.5% and hereditary persistence of foetal haemoglobin (HbA-HPFH) in 0.4%. Compared to the normal HbAA phenotype, HbAS had significantly increased mean cell haemoglobin concentration (MCHC), red cell count (RBC), and red cell distribution width (RDW) and decreased mean cell volume (MCV) and mean cell haemoglobin (MCH), these differences being even more marked in HbAC. Compared to HbAA, the HbA-HPFH had significantly increased RDW, but there were no consistent differences in other red cell indices, and there were no significant differences in haematological indices between the two common deletion HPFH variants, HPFH-1 and HPFH-2. Although these changes are unlikely to be clinically significant, they contribute to an understanding of the haematological spectrum of the common haemoglobin genotypes in peoples of African origin.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Haemoglobin C trait; Jamaica; Normal AA genotype; Red cell indices; Sickle cell trait

Year:  2022        PMID: 35018573      PMCID: PMC8941006          DOI: 10.1007/s12687-021-00575-8

Source DB:  PubMed          Journal:  J Community Genet        ISSN: 1868-310X


  15 in total

1.  Clinical manifestations of hemoglobin C disorders.

Authors:  E W SMITH; J R KREVANS
Journal:  Bull Johns Hopkins Hosp       Date:  1959-01

2.  Fetal haemoglobin levels and haematological characteristics of compound heterozygotes for haemoglobin S and deletional hereditary persistence of fetal haemoglobin.

Authors:  Duyen A Ngo; Banu Aygun; Idowu Akinsheye; Jane S Hankins; Ishir Bhan; Hong Y Luo; Martin H Steinberg; David H K Chui
Journal:  Br J Haematol       Date:  2011-10-24       Impact factor: 6.998

3.  Influence of hemoglobin phenotype on the mean erythrocyte volume.

Authors:  R G Sheehan; E P Frenkel
Journal:  Acta Haematol       Date:  1983       Impact factor: 2.195

4.  Red blood cell counts and indices in sickle cell trait in a black American population.

Authors:  O Castro; R B Scott
Journal:  Hemoglobin       Date:  1985       Impact factor: 0.849

5.  Hemoglobin phenotype and mean erythrocyte volume in Sicilian people.

Authors:  A Maggio; F Gagliano; S Siciliano
Journal:  Acta Haematol       Date:  1984       Impact factor: 2.195

6.  Red cell life span in sickle cell trait.

Authors:  M M Barbedo; P R McCurdy
Journal:  Acta Haematol       Date:  1974       Impact factor: 2.195

7.  Iron Deficiency among Jamaican Adolescents.

Authors:  K Mason; F Gibson; I Hambleton; B Serjeant; G Serjeant
Journal:  West Indian Med J       Date:  2015-02-26       Impact factor: 0.171

8.  Rapid detection of deletions causing delta beta thalassemia and hereditary persistence of fetal hemoglobin by enzymatic amplification.

Authors:  J E Craig; R A Barnetson; J Prior; J L Raven; S L Thein
Journal:  Blood       Date:  1994-03-15       Impact factor: 22.113

9.  The xerocytosis of Hb SC disease.

Authors:  S K Ballas; J Larner; E D Smith; S Surrey; E Schwartz; E F Rappaport
Journal:  Blood       Date:  1987-01       Impact factor: 22.113

10.  Haemoglobin Variant Screening in Jamaica: Meeting Student's Request.

Authors:  Karlene Mason; Felicea Gibson; Douglas Higgs; Chris Fisher; Swee L Thein; Barnaby Clark; Andreas Kulozik; Margit Happich; Beryl Serjeant; Graham Serjeant
Journal:  Br J Haematol       Date:  2015-06-30       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.